Clinical and Translational Research
Copyright ©The Author(s) 2022.
World J Gastrointest Oncol. Feb 15, 2022; 14(2): 498-510
Published online Feb 15, 2022. doi: 10.4251/wjgo.v14.i2.498
Table 1 Association of alpha-L-fucosidase-1 and matrix metalloproteinase 9 expression with clinicopathological characteristics in patients with resected esophageal squamous cell carcinoma from Sun Yat-Sen University Cancer Center
Variable
FUCA1 expression
MMP-9 expression
Low expression (n = 29)
High expression (n = 90)
P value
Low expression (n = 57)
High expression (n = 62)
P value
Age (yr, mean ± SD)61.2 ± 7.658.3 ± 9.20.13759.5 ± 8.458.6 ± 9.40.587
Female, n (%)3 (10.3)18 (20.0)0.2366 (10.5)15 (24.2)0.058
History of smoking, n (%)6 (20.7)33 (36.7)0.11145 (78.9)35 (56.5)0.009a
History of alcohol use, n (%)10 (34.5)35 (38.9)0.67041 (71.9)33 (53.2)0.036
Localization, n (%)
Upper2 (6.9)12 (13.3)0.3605 (8.8)9 (14.5)0.555
Middle20 (69.0)49 (54.4)33 (57.9)36 (58.1)
Lower7 (24.1)29 (32.2)19 (33.3)17 (27.4)
Grade, n (%)
Well4 (13.8)19 (21.1)0.64812 (21.1)11 (17.7)0.820
Moderately16 (55.2)48 (53.3)31 (54.4)33 (53.2)
Poorly9 (31.0)23 (25.6)14 (24.6)18 (29.0)
T stage, n (%)
T1-26 (20.7)22 (24.4)0.67812 (21.1)16 (25.8)0.541
T3-4a23 (79.3)68 (75.6)45 (78.9)46 (74.2)
Lymphatic invasion, n (%)
Negative (N0)20 (69.0)34 (47.8)0.003a31 (54.4)23 (37.1)0.067
Positive (N+)9 (31.0)56 (62.2)26 (45.6)39 (62.9)
TNM stage, n (%)
I-II18 (62.1)35 (38.9)0.029a29 (50.9)24 (38.7)0.182
III11 (37.9)55 (61.1)28 (49.1)38 (61.3)
Postoperative complication, n (%)
Arrhythmia5 (17.2)22 (24.4)0.42116 (28.1)11 (17.7)0.179
Pneumonia1 (3.4)11 (12.2)0.1725 (8.8)7 (11.3)0.649
Anastomotic leak0 (0)11 (12.2)0.048a4 (7.0)7 (11.3)0.421
Adjuvant therapy, n (%)19 (65.5)61 (67.8)0.82236 (63.2)44 (71.0)0.365
FUCA1 total score (mean ± SD)---4.3 ± 3.87.3 ± 4.10.000a
High FUCA1 expression, n (%)---36 (63.2)54 (87.1)0.002a
MMP-9 total score (mean ± SD)3.6 ± 2.72.3 ± 2.60.029a---
High MMP-9 expression, n (%)8 (27.6)54 (60.0)0.002a---